KR20230096976A - 사이클로덱스트린을 이용한 콜레스테롤 결정 색전증 예방 방법 - Google Patents

사이클로덱스트린을 이용한 콜레스테롤 결정 색전증 예방 방법 Download PDF

Info

Publication number
KR20230096976A
KR20230096976A KR1020237010391A KR20237010391A KR20230096976A KR 20230096976 A KR20230096976 A KR 20230096976A KR 1020237010391 A KR1020237010391 A KR 1020237010391A KR 20237010391 A KR20237010391 A KR 20237010391A KR 20230096976 A KR20230096976 A KR 20230096976A
Authority
KR
South Korea
Prior art keywords
cyclodextrin
beta
subject
hydroxypropyl
cholesterol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
KR1020237010391A
Other languages
English (en)
Korean (ko)
Inventor
다이애나 커윈
제이슨 캠
Original Assignee
베렌 테라퓨틱스 피.비.씨.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 베렌 테라퓨틱스 피.비.씨. filed Critical 베렌 테라퓨틱스 피.비.씨.
Publication of KR20230096976A publication Critical patent/KR20230096976A/ko
Withdrawn legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/724—Cyclodextrins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
KR1020237010391A 2020-08-27 2021-08-27 사이클로덱스트린을 이용한 콜레스테롤 결정 색전증 예방 방법 Withdrawn KR20230096976A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063071243P 2020-08-27 2020-08-27
US63/071,243 2020-08-27
PCT/US2021/048075 WO2022047244A1 (en) 2020-08-27 2021-08-27 Methods for the prevention of cholesterol crystal embolization with cyclodextrins

Publications (1)

Publication Number Publication Date
KR20230096976A true KR20230096976A (ko) 2023-06-30

Family

ID=80352440

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020237010391A Withdrawn KR20230096976A (ko) 2020-08-27 2021-08-27 사이클로덱스트린을 이용한 콜레스테롤 결정 색전증 예방 방법

Country Status (11)

Country Link
US (1) US20230302042A1 (https=)
EP (1) EP4203973A4 (https=)
JP (1) JP2023543132A (https=)
KR (1) KR20230096976A (https=)
CN (1) CN116635007A (https=)
AU (1) AU2021331485A1 (https=)
BR (1) BR112023003490A2 (https=)
CA (1) CA3190764A1 (https=)
IL (1) IL300881A (https=)
MX (1) MX2023002420A (https=)
WO (1) WO2022047244A1 (https=)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4877778A (en) * 1987-07-01 1989-10-31 The Children's Medical Center Corporation Method of enhancing lipophile transport using cyclodextrin derivatives
MX371073B (es) * 2012-04-13 2020-01-15 L&F Res Llc Método para utilizar ciclodextrina.

Also Published As

Publication number Publication date
CA3190764A1 (en) 2022-03-03
EP4203973A4 (en) 2024-08-21
US20230302042A1 (en) 2023-09-28
BR112023003490A2 (pt) 2023-05-09
JP2023543132A (ja) 2023-10-13
MX2023002420A (es) 2023-07-11
IL300881A (en) 2023-04-01
CN116635007A (zh) 2023-08-22
EP4203973A1 (en) 2023-07-05
AU2021331485A1 (en) 2023-03-23
WO2022047244A1 (en) 2022-03-03

Similar Documents

Publication Publication Date Title
JP7487264B2 (ja) ５－コレステン－３，２５－ジオール，３－サルフェート（２５ｈｃ３ｓ）又は薬学的に許容される塩及び少なくとも１種の環状オリゴ糖を含む組成物
JP7835735B2 (ja) シクロデキストリンによるコレステロール結晶塞栓症の治療方法
AU2014363270A1 (en) Compositions based on methyl cyclodextrins for the treatment and/or prevention of diseases by increasing the HDL cholesterol level
CN108366963A (zh) 包含丹曲林的水性组合物
JP2018531268A6 (ja) ダントロレンを含む水性組成物
CN102458110A (zh) 扩散促进化合物及其单独或与溶栓药一起的应用
JP2016507486A (ja) 腎臓病の治療に使用されるアーテミシニンおよびその誘導体
KR20230096976A (ko) 사이클로덱스트린을 이용한 콜레스테롤 결정 색전증 예방 방법
US20230375576A1 (en) Methods for the treatment of familial heterozygous and homozygous hypercholesterolemia with cyclodextrins
US20230091966A1 (en) Methods for the treatment of cardiovascular disease with cyclodextrins
WO2022199551A1 (en) Dc009 for treating acute ischemic stroke
TW202342072A (zh) 以環糊精治療高三酸甘油脂血症之方法
CN116782911A (zh) 治疗性化合物、组合物及其使用方法

Legal Events

Date Code Title Description
PA0105 International application

St.27 status event code: A-0-1-A10-A15-nap-PA0105

P11-X000 Amendment of application requested

St.27 status event code: A-2-2-P10-P11-nap-X000

P13-X000 Application amended

St.27 status event code: A-2-2-P10-P13-nap-X000

PG1501 Laying open of application

St.27 status event code: A-1-1-Q10-Q12-nap-PG1501

PC1203 Withdrawal of no request for examination

St.27 status event code: N-1-6-B10-B12-nap-PC1203